FindTrial
Sign In

A randomized controlled trial for the efficacy of total hip arthroplasty with DAA or posterior lateral approach

A randomized controlled trial for the efficacy of total hip arthroplasty with DAA or posterior lateral approach

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800019816
Enrollment
Unknown
Registered
2018-11-30
Start date
2018-11-30
Completion date
Unknown
Last updated
2018-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip disease

Interventions

DAA group:DAA approach
control group:conventional posterior lateral approach

Sponsors

Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 90 Years

Inclusion criteria

Inclusion criteria: Initial bilateral THA, hip osteoarthritis, avascular necrosis of the femoral head, DDH, informed consent, signed informed consent, and participation in clinical studies.

Exclusion criteria

Exclusion criteria: Patients with severe medical disease comorbidities, severe hip anatomical deformity, history of hip infection, ipsilateral lower extremity malformation, ipsilateral joint disease, spinal disease, adverse effects on gait or weight Muscle disease.

Design outcomes

Primary

MeasureTime frame
operation time;incision length;Intraoperative blood loss;Drainage;pain VAS score;HARRIS score;Gait analysis parameters;Prosthesis position;Satisfaction VAS;complication;—

Contacts

Public ContactGuo-Chun Zha

Affiliated Hospital of Xuzhou Medical University

41049015@qq.com+86 17712136030

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 14, 2026